CONMED Corporation Announces Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Conmed (CNMD) Tops Q2 EPS by 9c, Offers Guidance
July 28, 2021 4:13 PM EDTConmed (NASDAQ: CNMD) reported Q2 EPS of $0.71, $0.09 better than the analyst estimate of $0.62. Revenue for the quarter came in at $255.2 million versus the consensus estimate of $248.31 million.
GUIDANCE:
Conmed sees FY2021 EPS of $3.15-$3.25, versus the consensus of $3.15. Conmed sees... More



